Study S000685

Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07319286
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1; PHASE2
Masking: NONE
Status: ENROLLING_BY_INVITATION
Enrollment: 50
Start: 2025-08-04
Primary completion: 2026-12
Lead sponsor: Ain Shams University
Conditions: Menstrual Irregularities; Type1 Diabetes Mellitus; Glucagon-Like Peptide-1 Receptor Agonists; Female Reproductive Health
Interventions: DRUG:Dulaglutide
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Frequency of Self-Reported Menstrual Irregularities [Baseline]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0008114	Effectiveness and Safety of GLP-1 Receptor Agonists in Patients with Type 1 Diabetes. Almohareb SN, Journal of clinical medicine	2024	Nonrandomized study	PMID 39518671 DOI	registry reference RESULT:39518671